Here is the latest financial fact sheet of PLETHICO PHARMA. For more details, see the PLETHICO PHARMA quarterly results and PLETHICO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -4.9 |
No. of shares | m | 34.07 |
1 Week | % | -4.9 |
1 Month | % | -5.6 |
1 Year | % | -70.2 |
52 week H/L | Rs | 36.9/7.6 |
No. of Mths Year Ending |
12 Dec-09* |
12 Dec-10* |
12 Dec-11* |
12 Dec-12* |
12 Mar-14* |
5-Yr Chart Click to enlarge
|
---|
PLETHICO PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 381 | 450 | 395 | 397 | 254 | |
Low | Rs | 81 | 312 | 331 | 156 | 31 | |
Sales per share (Unadj.) | Rs | 365.8 | 446.4 | 453.6 | 478.9 | 604.6 | |
Earnings per share (Unadj.) | Rs | 58.9 | 67.7 | 30.2 | 29.8 | 32.5 | |
Diluted earnings per share | Rs | 58.9 | 67.7 | 30.2 | 29.8 | 32.5 | |
Cash flow per share (Unadj.) | Rs | 63.8 | 75.5 | 35.4 | 35.0 | 51.3 | |
Dividends per share (Unadj.) | Rs | 2.50 | 2.50 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 2.50 | 2.50 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 1.1 | 0.7 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 261.1 | 314.4 | 394.7 | 401.2 | 473.7 | |
Adj. book value per share | Rs | 261.2 | 314.4 | 394.8 | 401.3 | 473.7 | |
Shares outstanding (eoy) | m | 34.07 | 34.07 | 34.07 | 34.07 | 34.07 | |
Price / Sales ratio | x | 0.6 | 0.9 | 0.8 | 0.6 | 0.2 | |
Avg P/E ratio | x | 3.9 | 5.6 | 12.0 | 9.3 | 4.4 | |
P/CF ratio (eoy) | x | 3.6 | 5.0 | 10.3 | 7.9 | 2.8 | |
Price / Book Value ratio | x | 0.9 | 1.2 | 0.9 | 0.7 | 0.3 | |
Dividend payout | % | 4.2 | 3.7 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 7,864 | 12,984 | 12,359 | 9,424 | 4,859 | |
Total wages/salary | Rs m | 1,039 | 1,111 | 1,047 | 1,140 | 1,547 |
PLETHICO PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 12,464 | 15,209 | 15,456 | 16,315 | 20,598 | |
Other income | Rs m | 107 | 81 | 861 | 329 | 419 | |
Total revenues | Rs m | 12,571 | 15,290 | 16,317 | 16,644 | 21,017 | |
Gross profit | Rs m | 2,351 | 3,134 | 1,515 | 1,612 | 2,938 | |
Depreciation | Rs m | 166 | 264 | 176 | 177 | 642 | |
Interest | Rs m | 352 | 395 | 888 | 670 | 1,747 | |
Profit before tax | Rs m | 1,940 | 2,555 | 1,312 | 1,093 | 968 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -66 | 248 | 283 | 78 | -138 | |
Profit after tax | Rs m | 2,006 | 2,307 | 1,029 | 1,015 | 1,107 | |
Gross profit margin | % | 18.9 | 20.6 | 9.8 | 9.9 | 14.3 | |
Effective tax rate | % | -3.4 | 9.7 | 21.6 | 7.1 | -14.3 | |
Net profit margin | % | 16.1 | 15.2 | 6.7 | 6.2 | 5.4 |
PLETHICO PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 7,427 | 9,381 | 15,007 | 17,009 | 18,877 | |
Current liabilities | Rs m | 883 | 1,800 | 8,601 | 10,963 | 11,896 | |
Net working cap to sales | % | 52.5 | 49.8 | 41.4 | 37.1 | 33.9 | |
Current ratio | x | 8.4 | 5.2 | 1.7 | 1.6 | 1.6 | |
Inventory Days | Days | 58 | 48 | 47 | 45 | 78 | |
Debtors Days | Days | 133 | 153 | 229 | 274 | 198 | |
Net fixed assets | Rs m | 8,134 | 8,654 | 10,453 | 10,218 | 14,269 | |
Share capital | Rs m | 341 | 341 | 341 | 341 | 341 | |
"Free" reserves | Rs m | 8,556 | 10,369 | 13,108 | 13,329 | 15,798 | |
Net worth | Rs m | 8,897 | 10,710 | 13,449 | 13,670 | 16,139 | |
Long term debt | Rs m | 6,124 | 5,811 | 3,193 | 2,558 | 4,706 | |
Total assets | Rs m | 15,609 | 18,062 | 25,460 | 27,227 | 33,146 | |
Interest coverage | x | 6.5 | 7.5 | 2.5 | 2.6 | 1.6 | |
Debt to equity ratio | x | 0.7 | 0.5 | 0.2 | 0.2 | 0.3 | |
Sales to assets ratio | x | 0.8 | 0.8 | 0.6 | 0.6 | 0.6 | |
Return on assets | % | 15.1 | 15.0 | 7.5 | 6.2 | 8.6 | |
Return on equity | % | 22.5 | 21.5 | 7.7 | 7.4 | 6.9 | |
Return on capital | % | 15.3 | 17.9 | 13.2 | 10.9 | 13.0 | |
Exports to sales | % | 24.8 | 17.2 | 17.8 | 19.5 | 21.4 | |
Imports to sales | % | 4.0 | 1.1 | 6.2 | 14.1 | 15.2 | |
Exports (fob) | Rs m | 3,085 | 2,623 | 2,745 | 3,175 | 4,402 | |
Imports (cif) | Rs m | 496 | 169 | 960 | 2,306 | 3,136 | |
Fx inflow | Rs m | 3,085 | 2,623 | 2,745 | 3,175 | 4,402 | |
Fx outflow | Rs m | 796 | 303 | 1,089 | 2,364 | 3,184 | |
Net fx | Rs m | 2,289 | 2,320 | 1,655 | 811 | 1,219 |
PLETHICO PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,654 | 1,764 | -2,717 | -610 | 2,437 | |
From Investments | Rs m | -334 | -847 | -997 | 75 | -6,265 | |
From Financial Activity | Rs m | -1,232 | -853 | 3,567 | -405 | 2,490 | |
Net Cashflow | Rs m | 40 | -99 | 699 | -788 | 24 |
Share Holding
Shareholding as on Jun 2016
|
Company Information
|
CHM: Shashikant Patel | YEAR OF INC: 1991 | BSE CODE: 532739 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare PLETHICO PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.